ISPOR - HTA43 The Practice of Drug Clinical Comprehensive Evaluation in China and the Implications in Patient Access to Innovative Drugs

Full Text

HTA43 The Practice of Drug Clinical Comprehensive Evaluation in China and the Implications in Patient Access to Innovative Drugs

Abstract

Authors

Y Xing R Sun L Han Q Ye Y Lei T Xiong

Back to Volume 25, Supplemental Issue 7S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now